Scarica l'app Stockscreener
17.45
15.41%
2.33
Cidara Therapeutics Inc Azioni (CDTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
51.87%
8.463
|
17.58 | 12.72 | 7.497 | 26.11 |
Operating Expenses
|
9.90%
19.15
|
21.26 | 22.21 | 21.59 | 23.33 |
| Benefits Costs and Expenses |
100.00%
-
|
20.73 | 21.59 | 20.97 | - |
| Costs And Expenses |
7.61%
19.15
|
20.73 | 21.59 | 20.97 | 23.33 |
| Depreciation and Amortization |
9.09%
0.036
|
0.033 | 0.022 | 0.025 | 0.032 |
| Operating Income/Loss |
190.83%
-10.69
|
-3.676 | -9.49 | -14.10 | 2.781 |
| Income/Loss From Continuing Operations Before Tax |
368.75%
8.463
|
-3.149 | -8.877 | -13.47 | 26.11 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.064 | 0.23 | 0.149 | - |
| Income/Loss From Continuing Operations After Tax |
221.38%
-10.33
|
-3.213 | -9.107 | -13.62 | 3.013 |
|
Net Income/Loss
|
221.38%
-10.33
|
-3.213 | -9.107 | -13.62 | 3.013 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | 0.636 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
337.59%
4.5378
|
1.037 | 90.29 | 90.12 | 78.64 |
| Diluted Average Shares |
337.59%
4.5378
|
1.037 | 90.29 | 90.12 | 101.19 |
| Basic Earnings Per Share |
7,500%
-2.28
|
-0.03 | -0.10 | -0.15 | 0.03 |
| Diluted Earnings Per Share |
7,500%
-2.28
|
-0.03 | -0.10 | -0.15 | 0.03 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | 0.677 |
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):